X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
AJANTA PHARMA Fact Sheet, AJANTA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Fact Sheet    (AJPH)

Here is the latest financial fact sheet of AJANTA PHARMA. For more details, see the AJANTA PHARMA quarterly results and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

AJANTA PHARMA Price History

Price Rs 961.4
Mkt Cap Rs m 84,551
Vol '000 5.3
P/E X 21.4
P/CF X 18.4
EPS (TTM) Rs 45.0
% ch % -0.4
No. of shares m 87.95
% ch week % -3.5
% ch 1-mth % 6.3
% ch 12-mth % -22.8
52 week H/L Rs 1,294.1/840.0
(As on Aug 23, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AJANTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
AJANTA PHARMA EQUITY SHARE DATA
High Rs7791,7202,0981,8181,422 
Low Rs2991,1031,3511,106898 
Sales per share (Unadj.) Rs166.1195.3223.4239.5233.5 
Earnings per share (Unadj.) Rs34.946.857.152.844.0 
Diluted earnings per shareRs35.247.357.653.344.0 
Cash flow per share (Unadj.) Rs40.851.864.059.552.2 
Dividends per share (Unadj.) Rs6.008.0013.0009.00 
Adj. dividends per shareRs6.058.0713.120.009.01 
Dividend yield (eoy) %1.10.60.800.8 
Book value per share (Unadj.) Rs94.8134.2176.6230.0255.1 
Adj. book value per shareRs95.6135.4178.2232.1255.3 
Shares outstanding (eoy) m88.7188.7788.7788.7788.02 
Bonus/Rights/Conversions  FV2---BB 
Price / Sales ratio x3.27.27.76.15.0 
Avg P/E ratio x15.430.130.227.726.4 
P/CF ratio (eoy) x13.227.226.924.622.2 
Price / Book Value ratio x5.710.59.86.44.5 
Dividend payout %17.217.122.8020.5 
Avg Mkt Cap Rs m47,797125,299153,062129,782102,081 
No. of employees `000NANANA6.86.8 
Total wages/salary Rs m2,0062,5662,9543,7654,307 
Avg. sales/employee Rs ThNMNMNM3,128.43,022.6 
Avg. wages/employee Rs ThNMNMNM554.0633.4 
Avg. net profit/employee Rs ThNMNMNM689.7569.1 
AJANTA PHARMA INCOME DATA
Net Sales Rs m14,73617,34019,83321,25820,554 
Other income Rs m168212239242211 
Total revenues Rs m14,90417,55120,07121,49920,765 
Gross profit Rs m5,0525,8716,8696,5845,664 
Depreciation Rs m516444612596721 
Interest Rs m594914412 
Profit before tax Rs m4,6455,5896,4826,2265,143 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-850000 
Tax Rs m1,4621,4331,4131,5391,273 
Profit after tax Rs m3,0994,1565,0684,6863,870 
Gross profit margin %34.333.934.631.027.6 
Effective tax rate %31.525.621.824.724.8 
Net profit margin %21.024.025.622.018.8 
AJANTA PHARMA BALANCE SHEET DATA
Current assets Rs m6,3347,6398,50612,23611,812 
Current liabilities Rs m2,4962,7152,4673,4613,776 
Net working cap to sales %26.028.430.541.339.1 
Current ratio x2.52.83.43.53.1 
Inventory Days Days3943396077 
Debtors Days Days6478597982 
Net fixed assets Rs m4,5836,9149,28411,14014,398 
Share capital Rs m177177177177175 
"Free" reserves Rs m8,18611,73215,50020,23722,277 
Net worth Rs m8,41111,90915,67720,41422,452 
Long term debt Rs m33314910107 
Total assets Rs m11,43414,88018,47724,48626,962 
Interest coverage x79.5115.3477.61,519.4444.3 
Debt to equity ratio x00000 
Sales to assets ratio x1.31.21.10.90.8 
Return on assets %27.628.327.519.214.4 
Return on equity %36.834.932.323.017.2 
Return on capital %52.846.841.430.523.0 
Exports to sales %54.754.9000 
Imports to sales %4.46.0000 
Exports (fob) Rs m8,0629,527000 
Imports (cif) Rs m6531,038000 
Fx inflow Rs m8,49410,42211,47711,66710,682 
Fx outflow Rs m1,2471,6782,2061,6162,102 
Net fx Rs m7,2478,7449,27110,0528,580 
AJANTA PHARMA CASH FLOW
From Operations Rs m 2,794 3,261 6,093 2,811 3,748 
From Investments Rs m -1,584 -2,091 -3,831 -2,561 -2,228 
From Financial Activity Rs m -1,052 -1,173 -2,018 -2 -1,475 
Net Cashflow Rs m 159 -3 244 248 45 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 73.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 1.6%
FIIs 7.6%
ADR/GDR 0.0%
Free float 17.0%
Shareholders 20,968
Pledged promoter(s) holding 4.4%
 

Company Information

REGD OFF Ajanta House, Charkop, Kandivli (W), Mumbai - 400 067
E-MAIL deodatta.pandit@ajantapharma.com WEB www.ajantapharma.com
TELEPHONE (022) 66061000 FAX (022) 6606 1200
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Kapoor & Parekh Assoc.
CHM: Mannalal B. Agrawal COMP SEC: Gaurang Shah YEAR OF INC: 1979 BSE CODE: 532331 FV (Rs): 5 DIV YIELD (%): 0.9

Read: AJANTA PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMA  ALEMBIC LTD  STRIDES PHARMA SCIENCE  DISHMAN PHARMA  ALEMBIC PHARMA  

Compare AJANTA PHARMA With:   ASTRAZENECA PHARMA  ALEMBIC LTD  STRIDES PHARMA SCIENCE  DISHMAN PHARMA  ALEMBIC PHARMA  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Views on news

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead (The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound (Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now (Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks (The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS